Table 1 Basic clinical characteristics of SAP patients with pneumonia in the training cohort.

From: Development and validation of a nomogram for predicting 30-day mortality in patients with severe acute pancreatitis and pneumonia

Variables

Survival (n = 170)

Mortality (n = 50)

P

Age, (years)

47.11 ± 12.44

53.38 ± 13.50

0.002

Gender, n(%)

  

0.332

Male

121 (71.18)

32 (64.00)

 

Female

49 (28.82)

18 (36.00)

 

Smoke, n(%)

70 (41.18)

9 (18.00)

0.003

Alcohol, n(%)

61 (35.88)

9 (18.00)

0.017

Year of admission, n(%)

  

0.286

Apr. 2017-Dec. 2019

119 (70.00)

31 (62.00)

 

Jan. 2020-May 2021

51 (30.00)

19 (38.00)

 

Season of admission, n(%)

  

< 0.001

Spring/Summer

97 (57.06)

15 (30.00)

 

Autumn/Winter

73 (42.94)

35 (70.00)

 

Pneumonia type, n(%)

  

0.035

Infection

76 (44.71)

14 (28.00)

 

SIRS

94 (55.29)

36 (72.00)

 

HR, cpm

111.00 (94.25, 124.00)

112.00 (98.50, 124.00)

0.650

RR, cpm

24.00 (20.00, 28.75)

23.50 (20.00, 30.00)

0.838

SBP, mmHg

137.81 ± 23.86

125.32 ± 27.98

0.002

DBP, mmHg

81.00 (73.00, 90.75)

74.00 (64.25, 85.00)

0.001

WBC, T/L

12.10 (9.20, 17.00)

13.75 (10.25, 17.25)

0.343

RBC, T/L

3.67 (2.96, 4.29)

2.85 (2.56, 3.61)

< 0.001

PLT, G/L

183.50 (139.25, 253.75)

157.00 (105.75, 224.25)

0.028

HB, g/L

110.76 ± 27.26

92.14 ± 29.33

< 0.001

HCT, %

33.44 ± 8.01

27.86 ± 8.67

< 0.001

RDW, %

14.25 (13.50, 15.00)

15.25 (14.25, 15.88)

< 0.001

ALB, g/L

30.50 (27.80, 33.85)

26.50 (24.83, 29.17)

< 0.001

K+, mmol/L

3.76 (3.38, 4.13)

4.06 (3.73, 4.48)

< 0.001

Na+, mmol/L

140.50 (137.10, 143.47)

144.15 (139.93, 147.60)

< 0.001

Ca2+, mmol/L

1.94 (1.78, 2.08)

1.96 (1.81, 2.09)

0.369

AST, U/L

37.05 (26.50, 59.62)

55.35 (29.48, 107.55)

0.014

TBIL, umol/L

19.55 (14.00, 36.75)

26.10 (16.18, 77.85)

0.028

BUN, mmol/L

6.83 (4.51, 11.41)

20.82 (12.59, 30.83)

< 0.001

CREA, umol/L

81.15 (64.55, 126.57)

302.00 (159.12, 422.87)

< 0.001

PT, s

13.90 (13.20, 15.67)

14.90 (13.48, 16.20)

0.037

INR

1.16 (1.07, 1.26)

1.25 (1.16, 1.40)

< 0.001

APTT, s

33.80 (30.10, 39.45)

37.30 (34.08, 42.87)

0.009

PH

7.44 (7.39, 7.49)

7.39 (7.31, 7.48)

0.012

PaO2, mmHg

73.00 (62.00, 86.75)

83.50 (71.00, 131.00)

0.002

Lac, mmol/L

1.40 (1.00, 1.78)

1.80 (1.22, 2.27)

< 0.001

Hypertension, n(%)

47 (27.65)

15 (30.00)

0.745

CeVD, n(%)

9 (5.29)

1 (2.00)

0.551

CVD, n(%)

9 (5.29)

5 (10.00)

0.385

DM, n(%)

44 (25.88)

10 (20.00)

0.396

Pulmonary disease, n(%)

6 (3.53)

3 (6.00)

0.712

Disease course phase, n(%)

  

0.325

Oneset

71 (41.76)

17 (34.00)

 

Recurrence

99 (58.24)

33 (66.00)

 
  1. Continuous variables are presented as mean ± standard deviation if normally distributed, or median (interquartile range) otherwise.
  2. ALB: Albumin; Apr.: April; APTT: Activated Partial; AST: Aspartate Amino Transferase; BUN: Blood urea nitrogen; Ca2+:Calcium; Concentration; CeVD: Cerebrovascular Disease; CREA: Creatinine; CVD: Cardiovascular Diseases; DBP: Diastolic Blood Pressure; DM: Diabetes Mellitus; HB: Hemoglobin; HCT: Haematocrit; HR: Heart Rate; INR: International Normalised Ratio; Jan: January; K+: Potassium Concentration; Lac: Lactic Acid; Na+: Sodium Concentration; PLT: Platelet; PaO2: Arterial Oxygen Partial Pressure; PT: Prothrombin Time; RBC: Red blood cell; RDW: Red Cell Distribution Width; RR: Respiratory Rate; SAP: Severe Acute Pancreatitis; SBP: Systolic Blood Pressure; SIRS: Systemic Inflammatory Response Syndrome; TBIL: Total Bilirubin; Temp: Temperature; WBC: White Blood Cell.
Back to article page